Covid-19 Statement



We are continuously monitoring the COVID-19 pandemic and proactively seeking advice from local, national and global health authorities on whether our events can run as planned.

In light of this, it may become necessary to postpone some of our events.

The 2nd Neuro-Immunology Drug Development Summit is due to go ahead as planned on August 5-7 in Boston.

As the situation is dynamic, we have introduced a risk-free booking policy so that you can book with confidence:

  • If we need to reschedule an event we will automatically transfer your ticket to the new dates.
  • If this isn’t suitable, we can offer you a credit voucher for anyone in your company to attend an event of your/their choice or a full refund.*

You can register here risk-free.

We will continue to track the situation and to be guided by the advice of the US Government, the CDC, and the World Health Organization. Should you wish to be kept informed about date changes or major updates, please let us know here.


*Full refunds are available for those customers booking from the 31st March and are only available for bookings made where this condition is specified. Please let us know within 7 days of an event being moved if you would like to take up this option. Hanson Wade reserves the right to return to standard terms and conditions at a later date.

If you have any questions or concerns relating to the COVID-19 outbreak and how it will affect the meeting, please contact us via the link below: